Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Second Opinion Expert Announces Launch of VACCINEPLUS™ COVID-19 Virtual Vaccination Card

Turns paper vaccination card into a medically verified virtual vaccination card on a smartphone


News provided by

SecondOpinionExpert, Inc.

Oct 20, 2021, 11:00 ET

Share this article

Share toX

Share this article

Share toX

VaccinePlus™ Card
VaccinePlus™ Card

DANA POINT, Calif., Oct. 20, 2021 /PRNewswire-PRWeb/ -- The SOE VaccinePlus™ Card is a safe and secure medical record that combines vaccine card information with results of an antibody test in a single verified "virtual vaccine card" that delivers confidence about COVID-19 vaccination status. The VaccinePlus™ Card uses a medical approach to give holders information about the efficacy of the vaccine they received, so that they can make more informed decisions about maintaining their health, as well as protecting others from the COVID-19 virus.

The goal of a vaccine is to create antibodies that guard against infection. Not everyone who gets a vaccine will develop a sufficient quantity of antibodies to provide adequate protection. By utilizing a certain type of COVID-19 antibody test, SOE can confirm if the user's vaccine "worked" by creating the required antibodies. While it is not yet known what amount of protection different levels of antibodies confer, when a vaccinated person has antibodies above the testing threshold, it is extremely rare for the person to have a severe infection leading to hospitalization or death.

“Your SOE VaccinePlus™ Card can be easily verified using the scan code displayed right on your smartphone. We are pleased to offer this free service to help patients make informed decisions about their health while helping to expedite the safe reopening of our economy,” Krause said.

Post this

SOE's VaccinePlus™ Card is also an innovative solution for organizations that need to create a reassuring environment for participants at social events or business gatherings. It is a safe and trustworthy way for people to share their vaccine status with each other.

The fast and easy-to-use service is being provided by SOE free of charge as a community service. To comply with current guidelines of the Cares Act, the testing lab may collect the user's insurance information, however, at present there is no charge for the testing regardless of insurance status.

To obtain a VaccinePlus™ Card, users log in at http://www.soe.care to upload a photo or scan of their paper vaccine record and answer a few quick online questions. (Users should wait at least two weeks after their last required dose of the vaccine before requesting the card.) SOE then reviews that information and if all is in order, SOE will provide the user with a doctor-prescribed lab order for an antibody test at a specific nationwide lab. The patient visits the nearest lab location for the necessary blood draw and test. The results from that test are sent directly to SOE, ensuring the process is clear from any suspicion of fraud. A positive test serves as medical verification that the user got vaccinated.

Vaccine data and positive antibody test results both appear in the VaccinePlus™ Card, which is delivered to the user's smartphone where it is easily accessible. It contains a QR code that can be quickly scanned by others, querying SOE's secure database to validate vaccination and test results. No special apps are required and no information is shared unless initiated by the user.

"This simple, safe and secure solution combines COVID-19 vaccine card information with results of an antibody test in a single verified virtual vaccine card providing users with easy-to-access digital proof of their vaccination status," said Steve Krause, President, SecondOpinionExpert, Inc. "Your SOE VaccinePlus™ Card can be easily verified using the scan code displayed right on your smartphone. We are pleased to offer this free service to help patients make informed decisions about their health while helping to expedite the safe reopening of our economy," Krause said.

The VaccinePlus™ Card is available now at http://www.soe.care

About SecondOpinionExpert
SecondOpinionExpert's online technology increases the quality and efficiency of healthcare delivery, improves healthcare access and empowers patients to make better informed medical decisions. The HIPAA-compliant patented platform leverages recent advancements in information technology and electronic medical record systems enabling the company to provide fast, reliable and secure online medical opinions. The system provides patients greater peace of mind in knowing that they have a medical expert's perspective for their medical decisions.

SOE offers exclusive, one-on-one, online, professional diagnostic evaluations to patients across the United States and around the globe. We also offer attractive plans for utilizing second opinions as an employee benefit, which helps hold down rising health care premiums. Our skilled panel is composed of hundreds of physician specialists with exemplary academic credentials as well as significant patient care experience in all major diagnostic specialties and subspecialties. Utilizing our patented technology and databases, our physicians can more efficiently and effectively review a patient's prior tests and symptoms when writing a second opinion report. Thereafter, the physician can also be available for a follow-up teleconference with the patient for meaningful counseling and treatment advice.

Our technology is available for use here in the US and worldwide. Our patent is also available to be licensed, and the platform can be customized for government, institutional or enterprise use.

Additional information can be found at http://www.soe.care

Media Contact

Steve Krause, President, SecondOpinionExpert, Inc., +1 818 970 7333, [email protected]

Twitter, Facebook

SOURCE SecondOpinionExpert, Inc.

Related Links

http://www.soe.care

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.